Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis

Efe, Cumali; Al Taii, Haider; Ytting, Henriette; Aehling, Niklas; Bhanji, Rahima; Hagstrom, Hannes; PÜRNAK, TUĞRUL; Muratori, Luigi; Werner, Marten; Muratori, Paolo; Klintman, Daniel; Schiano, Thomas; Montano-Loza, Aldo; Berg, Thomas; Larsen, Fin; Alkhouri, Naim; Ozaslan, Ersan; Heneghan, Michael; Yoshida, Eric; Wahlin, Staffan

doi:10.1007/s10620-018-5011-x

Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis

Efe C., Al Taii H., Ytting H., Aehling N., Bhanji R. A., Hagstrom H., ...More

DIGESTIVE DISEASES AND SCIENCES, vol.63, no.5, pp.1348-1354, 2018 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 63 Issue: 5
Publication Date: 2018
Doi Number: 10.1007/s10620-018-5011-x
Journal Name: DIGESTIVE DISEASES AND SCIENCES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1348-1354
Hacettepe University Affiliated: Yes

Abstract

We studied the efficacy and safety of mycophenolate mofetil (MMF) and tacrolimus as second-line therapy in pediatric patients with autoimmune hepatitis (AIH) who were intolerant or non-responders to standard therapy (corticosteroid and azathioprine).